You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Marqibo

Showing 1 - 25 of 29
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-cell Acute Lymphoblastic Leukemia Trial in Tampa, Durham, Winston-Salem (Blinatumomab)

Withdrawn
  • B-cell Acute Lymphoblastic Leukemia
  • Tampa, Florida
  • +2 more
Feb 14, 2022

Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Mantle-Cell Trial in Providence (Rituximab, Bendamustine, Vincristine

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • +5 more
  • Providence, Rhode Island
    Rhode Island Hospital and The Miriam Hospital
Jul 19, 2021

Leukemia Trial in Portland (cyclophosphamide, cytarabine, dexamethasone)

Terminated
Has Results
  • Leukemia
  • Portland, Oregon
    OHSU Knight Cancer Institute
Dec 13, 2022

Acute Lymphoblastic Leukemia (ALL) Trial in United States (Vincristine Sulfate Liposomes Injection (VSLI), Vincristine Sulfate

Terminated
Has Results
  • Acute Lymphoblastic Leukemia (ALL)
  • Vincristine Sulfate Liposomes Injection (VSLI)
  • Vincristine Sulfate Injection (VSI)
  • La Jolla, California
  • +14 more
Sep 6, 2021

B-cell Lymphoma, Burkitt Lymphoma Trial in Milwaukee (Etoposide, Doxorubicin, Cyclophosphamide)

Not yet recruiting
  • B-cell Lymphoma
  • Burkitt Lymphoma
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Jun 11, 2022

T-Cell Peripheral Lymphoma, Gamma Delta Hepatosplenic T-Cell Lymphoma, Subcutaneous Panniculitis-Like T-Cell Lymphoma Trial run

Completed
Has Results
  • T-Cell Peripheral Lymphoma
  • +3 more
  • Rituximab
  • +6 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 28, 2021

Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Blasts 5 Percent or More of Bone Marrow Nucleated Cells, Blasts 5

Withdrawn
  • Allogeneic Hematopoietic Stem Cell Transplantation Recipient
  • +7 more
  • Inotuzumab Ozogamicin
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jan 13, 2022

Acute Lymphoblastic Leukemia (ALL) Trial in Worldwide (Marqibo® (vincristine sulfate liposomes injection))

Completed
Has Results
  • Acute Lymphoblastic Leukemia (ALL)
  • Marqibo® (vincristine sulfate liposomes injection)
  • Los Angeles, California
  • +32 more
Feb 8, 2021

Hematologic Diseases Trial (Vincristine Sulfate Liposome, CHOP, R-CHOP)

Unknown status
  • Hematologic Diseases
  • Vincristine Sulfate Liposome
  • +2 more
  • (no location specified)
Apr 15, 2020

Sarcoma, Neuroblastoma, Wilms Tumor Trial run by the (Marqibo)

Completed
  • Sarcoma
  • +5 more
  • Marqibo
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 14, 2020

Intraocular Retinoblastoma Trial in United States (drug, procedure, biological)

Completed
Has Results
  • Intraocular Retinoblastoma
  • liposomal vincristine sulfate
  • +5 more
  • Arcadia, California
  • +10 more
Jul 12, 2021

Metastatic Malignant Uveal Melanoma Trial in United States (Marqibo® (vincristine sulfate liposomes injection))

Completed
Has Results
  • Metastatic Malignant Uveal Melanoma
  • Marqibo® (vincristine sulfate liposomes injection)
  • Los Angeles, California
  • +3 more
Nov 27, 2019

ALL, Childhood, Lymphoblastic Leukemia, Acute, Childhood, Lymphoblastic Leukemia, Acute Trial in Australia, Canada, United

Recruiting
  • ALL, Childhood
  • +2 more
  • Marqibo
  • Los Angeles, California
  • +34 more
Apr 15, 2020

Recurrent Acute Lymphoblastic Leukemia, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Burkitt Leukemia Trial in Houston

Recruiting
  • Recurrent Acute Lymphoblastic Leukemia
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 21, 2022

Malignant Melanoma Trial in Houston (Vincristine Sulfate Liposomes Injection)

Completed
Has Results
  • Malignant Melanoma
  • Vincristine Sulfate Liposomes Injection
  • Houston, Texas
    University of Texas M.D. Anderson Cancer Center
Dec 10, 2019

Acute Lymphoblastic Leukemia Trial in Atlanta, Chicago, Houston (Vincristine Sulfate Liposomes Injection, Dexamethasone)

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • Atlanta, Georgia
  • +2 more
Dec 10, 2019

Non-Hodgkin's Lymphoma, Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma Trial in San Francisco, Leeds (Vincristine Sulfate

Completed
  • Non-Hodgkin's Lymphoma
  • +2 more
  • Vincristine Sulfate Liposome Injection plus rituximab
  • San Francisco, California
  • +1 more
Dec 31, 2019

Recurrent Adult Acute Myeloid Leukemia Trial in Winston-Salem (Vincristine Sulfate Liposome, Laboratory Biomarker Analysis)

Terminated
Has Results
  • Recurrent Adult Acute Myeloid Leukemia
  • Vincristine Sulfate Liposome
  • Laboratory Biomarker Analysis
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jul 31, 2019

Intraocular Retinoblastoma Trial in Worldwide (liposomal vincristine sulfate, carboplatin, etoposide)

Completed
Has Results
  • Intraocular Retinoblastoma
  • liposomal vincristine sulfate
  • +2 more
  • Birmingham, Alabama
  • +55 more
Feb 16, 2021

CD20+ Aggressive B-Cell Lymphoma Trial in Germany (Conventional Vincristine, Liposomal Vincristine, Ricover-scheme rituximab)

Active, not recruiting
  • CD20+ Aggressive B-Cell Lymphoma
  • Conventional Vincristine
  • +3 more
  • Homburg, Saarland, Germany
  • +125 more
Nov 11, 2022

Acute Lymphoblastic Leukemia, Lymphoma, Non-Hodgkin's, Leukemia, T-Cell Trial in Memphis (Dexamethasone, Panobinostat, Liposomal

Terminated
Has Results
  • Acute Lymphoblastic Leukemia
  • +3 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Mar 8, 2019

Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage IV Childhood Hodgkin

Completed
Has Results
  • Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma
  • +2 more
  • bleomycin sulfate
  • +8 more
  • Birmingham, Alabama
  • +176 more
Apr 1, 2022

Stage III Wilms Tumor With Loss of Heterozygosity (LOH) for 1p and 16q, Stage IV Wilms Tumor Trial in Worldwide (drug,

Active, not recruiting
Has Results
  • Stage III Wilms Tumor With Loss of Heterozygosity (LOH) for 1p and 16q
  • Stage IV Wilms Tumor
  • doxorubicin hydrochloride
  • +6 more
  • Birmingham, Alabama
  • +206 more
Mar 23, 2022

Acute Lymphoblastic Leukemia Trial in United States (JCAR015 (CD19-targeted CAR T cells))

Terminated
Has Results
  • Acute Lymphoblastic Leukemia
  • JCAR015 (CD19-targeted CAR T cells)
  • Birmingham, Alabama
  • +17 more
Apr 30, 2020

Recurrent Adult Acute Lymphoblastic Leukemia, Refractory Adult Acute Lymphoblastic Leukemia Trial in Palo Alto, Baltimore

Withdrawn
  • Recurrent Adult Acute Lymphoblastic Leukemia
  • Refractory Adult Acute Lymphoblastic Leukemia
  • Laboratory Biomarker Analysis
  • +3 more
  • Palo Alto, California
  • +1 more
Dec 13, 2016